Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the performance and safety of electromagnetic navigation bronchoscopy (ENB) system and system kit (iLungTM SuperNavigator) .


Clinical Trial Description

This is prospective, randomized, multicenter, superiority study. 8 top centers in China was chosen. Subject which has peripheral lung lesions (PLLs) detected by chest CT scan, requires biopsy diagnosis, and meets all inclusion and exclusion criteria, will be included in this trial. Firstly physician determines the lesion biopsied, then the subject will be randomized to experimental or control group. The experimental group is treated with ENB guided transbronchial lung biopsy (TBLB)(ENB-TBLB): Under ENB guidance, the location sensor reaches the edge of the lesion, and X-ray is used for actual distance confirmation, if physician determines the distance is enough for biopsy, TBLB will be conducted. The control group will be treated with TBLB using X-ray guidance. ;


Study Design


Related Conditions & MeSH terms

  • Lung Lesion(s) Requiring Evaluation

NCT number NCT03628222
Study type Interventional
Source Changzhou LungHealth Medtech Company Limited
Contact Shiyue Li
Phone +8613902233925
Email lishiyue@188.com
Status Recruiting
Phase N/A
Start date January 4, 2019
Completion date June 2020

See also
  Status Clinical Trial Phase
Completed NCT04066699 - Percutaneous Localization: Open-label Registry of Thoracic Surgery
Completed NCT02410837 - NAVIGATE: Clinical Evaluation of superDimension™ Navigation System for Electromagnetic Navigation Bronchoscopy™